Bibliography of published COVID-19 in children literature

Philippa Anna Stilwell1, Alasdair P S Munro2,3, Emre Basatemur4

  • 1Department of Community Paediatrics, Evelina London Children's Hospital, London, UK.

Insights

Early COVID-19 research in children showed a publication surge, but many studies were small case reports. This highlights the need for cautious interpretation of pediatric COVID-19 findings during the pandemic.

Area of Science:

  • Pediatric Infectious Diseases
  • Epidemiology
  • Bibliometrics

Background:

  • The COVID-19 pandemic presented a significant global health challenge.
  • Understanding the role of children in SARS-CoV-2 transmission and the clinical impact of infection on pediatric populations is crucial.
  • This study analyzes publication trends in pediatric COVID-19 literature during the initial six months of the pandemic.

Purpose of the Study:

  • To describe the publication trends of scientific literature concerning COVID-19 in children.
  • To analyze the characteristics of research published on pediatric COVID-19 in the early pandemic period.

Main Methods:

  • A comprehensive search of preprint and published literature was conducted across four major databases (PubMed, Scopus, Ovid-Embase, MedRXiv) from January 1 to June 30, 2020.
  • Titles and abstracts were screened using predefined inclusion and exclusion criteria.
  • Bibliometric analysis was performed on the selected literature.

Main Results:

  • A total of 476 relevant papers were identified out of 45,453 retrieved articles.
  • These publications described a cumulative total of up to 41,396 children, with a median of 6 children per paper.
  • Nearly 60% of the papers reported on 9 or fewer children, and half of the publications originated from Asia.

Conclusions:

  • The number of pediatric COVID-19 publications increased steadily during the study period, reflecting evolving understanding and policy.
  • A significant proportion of early research consisted of individual case reports or small case series, potentially limiting their contribution to advancing knowledge.
  • Findings underscore the importance of cautious interpretation of early pandemic literature and continuous review of clinical/policy decisions based on emerging evidence.
Abstract

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.7K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.8K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.4K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.2K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.2K